A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 61 shares of ARCT stock, worth $1,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 5,852 98.96%
Holding current value
$1,008
Previous $142 Million 99.0%
% of portfolio
0.0%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $104,701 - $146,975
-5,791 Reduced 98.96%
61 $1.43 Million
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $142,496 - $259,770
5,852 New
5,852 $142 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.